Genes rarely fall neatly into categories of good or bad. A genetic variation that helps the immune system fight infection may also make it more likely to attack healthy tissue.

Research published in The American Journal of Human Genetics on 11 September 2026 reveals how a common lupus-associated genetic variant could produce precisely this trade-off, offering new insights into the relationship between inherited immunity and autoimmune disease.

<h3>When A Stronger Immune Response Backfires</h3>

The immune system relies on a complex network of signals to recognise infections and eliminate potential threats. One important component is IRF7, a gene that regulates the production of type I interferons, including interferon-alpha.

These signalling proteins help cells respond to invading viruses. However, excessive or prolonged interferon activity can contribute to autoimmune conditions such as systemic lupus erythematosus, commonly known as lupus.

In people with lupus, the immune system mistakenly attacks healthy tissues, sometimes affecting multiple organs. Researchers wanted to understand why a genetic variant associated with this condition remains remarkably common across human populations.

Their findings suggest that the answer may lie in its ability to strengthen antiviral protection.

<h3>An Ancient Genetic Advantage</h3>

The international research team investigated a common inherited combination of genetic variants, known as a haplotype, within the IRF7 gene.

Using genetic fine-mapping and ancient DNA analysis, the scientists established that this lupus-associated haplotype has persisted at high frequencies for thousands of years.

Laboratory experiments revealed how it changes immune activity. The risk-associated version increases the movement of IRF7 into the cell nucleus, strengthens its interaction with DNA and alters the sequences it recognises.

Consequently, certain immune cells, including monocytes and airway epithelial cells, produce more interferon-alpha when stimulated.

The researchers suggest that stronger antiviral responses may have provided an evolutionary advantage, potentially helping explain the variant's persistence. However, its historical survival benefit remains a hypothesis rather than a demonstrated fact.

<h3>Protection Comes At A Cost</h3>

To examine the biological consequences, the researchers used CRISPR gene editing to introduce a corresponding genetic change into mice.

The modified animals demonstrated better early control of vesicular stomatitis virus infection. However, in a separate experimental model of autoimmunity, they also developed higher levels of autoantibodies, which mistakenly target the body's own tissues.

The experiments revealed two contrasting effects of heightened IRF7 activity: improved antiviral defence and increased autoimmune responses.

First author Samuel Virolainen explained that the findings help clarify why a lupus-associated genetic variant remains widespread while also demonstrating its broader influence on immune function.

<h3>Connecting Genetics And Viral Infections</h3>

The discovery also contributes to a wider question: why do similar viral exposures produce very different immune responses between individuals?

Previous research has investigated connections between Epstein-Barr virus and lupus, but exposure alone cannot explain who develops the disease.

Research leader Leah Kottyan highlighted how inherited susceptibility and viral exposure may affect overlapping molecular pathways. Genetic differences can influence the strength of an immune response, while infections can activate those same pathways.

This interaction could help researchers better understand how protective immune activity sometimes develops into persistent autoimmune inflammation.

<h3>A New Perspective On Lupus</h3>

The findings do not mean that carrying this genetic variant will cause lupus. The condition involves numerous genetic and environmental factors, and important experimental results came from cells and animal models rather than clinical trials.

Nevertheless, understanding the mechanisms behind this immune trade-off could inform future treatments designed to control harmful inflammation while preserving essential antiviral protection.

The research offers a different perspective on disease-associated genes: some may persist not despite their biological effects, but partly because the same mechanisms can be beneficial under different circumstances.